A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05678218` - Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
Recruiting	`NCT05161572` - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer	Phase 2
Recruiting	`NCT02292641` - Beyond TME Origins	N/A
Withdrawn	`NCT05325164` - Methadone for 'Adenocarcinopathic' Pain Treatment	Phase 3
Completed	`NCT02926768` - Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors	Phase 1
Recruiting	`NCT02125240` - Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma	Phase 3
Completed	`NCT02374411` - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients	N/A
Completed	`NCT02454647` - Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients	N/A
Completed	`NCT01579721` - Prospective Randomized Study of SILS Versus CLS for Rectal Cancer	Phase 4
Withdrawn	`NCT01148082` - School Response to Families Who Have Children With Cancer	N/A
Completed	`NCT01206530` - FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer	Phase 1/Phase 2
Completed	`NCT00548548` - A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer	Phase 3
Completed	`NCT00129844` - Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer	Phase 2
Completed	`NCT00377936` - EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas	Phase 2
Completed	`NCT00183859` - Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan	Phase 1
Recruiting	`NCT01930864` - Metformin Plus Irinotecan for Refractory Colorectal Cancer	Phase 2
Completed	`NCT02498860` - Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung	Phase 2
Terminated	`NCT01441128` - -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer	Phase 1
Active, not recruiting	`NCT04400474` - Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study	Phase 2
Recruiting	`NCT02133196` - T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer	Phase 2

NCT number	NCT02943603
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Withdrawn
Phase	Phase 2
Start date	January 2017
Completion date	July 2019

A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms